Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2022-08-06 2022-08-05
Drug Identification Number 02523736 02523736
Brand name APO-GUANFACINE XR APO-GUANFACINE XR
Common or Proper name GUANFACINE XR GUANFACINE XR
Company Name APOTEX INC APOTEX INC
Ingredients GUANFACINE GUANFACINE
Strength(s) 2MG 2MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C02AC C02AC
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-07-19 2022-07-19
Estimated end date 2022-08-12 2022-08-12
Actual end date 2022-08-05 2022-08-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments